Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P577: Withdrawal of thiopurines in patients with Ulcerative Colitis in remissionECCO'21 Virtual
Year: 2021
Authors: Amor Costa, C.(1);Suárez Ferrer, C.(1);Poza Cordón, J.(1);Rueda García, J.L.(1);Sánchez Azofra, M.(1);Martín Arranz, E.(1);González Diaz, I.(1);Amiama Roig, C.(1);García Ramirez, L.(1);Martín Arranz, M.D.(1);
(1)Hospital La Paz Institute for Health Research - IdiPAZ La Paz University Hospital - Universidad Autónoma de Madrid, Gastroenterology and Hepatology, Madrid, Spain
P578: Adriatic-Balkan regional survey on COVID-19 in Inflammatory Bowel Disease patientsECCO'21 Virtual
Year: 2021
Authors: Borzan, V.(1,2);Orsic Fric, V.(1,2);Borzan, B.(3);
(1)Clinical Hospital Centre Osijek, Department of Gastroenterology and Hepatology, Osijek, Croatia;(2)Faculty of Medicine- J. J. Strossmayer University of Osijek, Department of Internal Medicine, Osijek, Croatia;(3)Community Health Center Osijek, Department of Occupational Medicine, Osijek, Croatia
P579: Online Education Significantly Improved Gastroenterologists' Knowledge of Treatment Options and Therapeutic Goals in Ulcerative ColitisECCO'21 Virtual
Year: 2021
Authors: Bell, E.(1);Calle, M.(2);Vermeire, S.(3);
(1)WebMD, Medscape Educational Global, London, United Kingdom;(2)WebMD, Medscape Education Global, Amsterdam, The Netherlands;(3)University Hospitals Leuven, Department of Gastroenterology, Leuven, Belgium
P580: Benchmarking IBD Pharmacy Services to optimise, strengthen and align IBD Expert Pharmacy PracticeECCO'21 Virtual
Year: 2021
Authors: St Clair Jones, A.(1);Meade, U.(2);
(1)Brighton and Sussex University Hospitals, Department of Gastroenterology- Department of Pharmacy, Brighton, United Kingdom;(2)St.Mark, Pharmacy, London, United Kingdom; IBDUK
P581: Pre-operative prolonged antibiotic treatment in ileocecal Crohn’s disease: single center non-randomized prospective study.ECCO'21 Virtual
Year: 2021
Authors: Vardanyan, A.(1);Ovsyannikova, V.(2);Peda , E.(3);Nanaeva, B.(3);Achkasov, S.(4);
(1)National medical research center of Coloproctology, IBD surgical department, Moscow, Russian Federation;(2)National medical research center of Coloproctology, IBD surgery department, Moscow, Russian Federation;(3)National medical research center of Coloproctology, Gastroenterology, Moscow, Russian Federation;(4)National medical research center of Coloproctology, Oncology and Colon Surgery Department, Moscow, Russian Federation
P582: Insights on the sphingolipid profile in patients with short bowel syndrome and consecutive intestinal failureECCO'21 Virtual
Year: 2021
Authors: Kubesch, A.(1);Knauer, F.(1);Thomas, D.(2);Jakobi, K.(3);Filmann, N.(4);Zeuzem, S.(1);Pfeilschifter, J.(3);Grammatikos, G.(1);Blumenstein, I.(1);
(1)Goethe-University Hospital, Department of Internal Medicine 1, Frankfurt, Germany;(2)Goethe-University Hospital, Institute of Clinical Pharmacology, Frankfurt, Germany;(3)Goethe-University Hospital, Institute of General Pharmacology and Toxicology, Frankfurt, Germany;(4)Goethe-University Hospital, Institute of Biostatistics and Mathematical Modeling, Frankfurt, Germany
P583: Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn’s disease: results from a large Italian cohort studyECCO'21 Virtual
Year: 2021
Authors: Mocci, G.(1);Cuomo, A.(2);Allegretta, L.(3);Aragona, G.(4);Colucci, R.(5);Della Valle, N.(6);Ferronato, A.(7);Forti, G.(8);Gaiani, F.(9);Graziani, M.G.(10);Lorenzetti, R.(11);Luzza, F.(12);Penna, A.(13);Pica, R.(14);Piergallini, S.(15);Rodinò, S.(16);Scarcelli, A.(17);Zampaletta, C.(18);Cicerone, C.(19);Cocco, A.(20);De Angelis, G.(9);Donnarumma, L.(2);Pranzo, G.(21);Franceschi, M.(7);Gallina, S.(18);Grasso, G.(3);Larussa, T.(12);Luppino, I.(22);Faggiani, R.(23);Fanigliulo, L.(24);Pagnini, C.(10);Perazzo, P.(4);Sacco, R.(6);Sebkova, L.(16);Serio, M.E.(25);De Monti, A.(26);Picchio, M.(27);Elisei, W.(28);Maconi, G.(26);Tursi, A.(29);
(1)Gastroenterology Unit, Internal Medicine- Brotzu Hospital, Cagliari, Italy;(2)Division of Gastroenterology, Umberto I” Hospital, Nocera Inferiore, Italy;(3)Division of Gastroenterology, 'Santa caterina Novella' Hospital, Galatina, Italy;(4)Division of Gastroenterology, 'Guglielmo da Saliceto' Hospital, Piacenza, Italy;(5)Digestive Endoscopy Unit, 'San Matteo degli Infermi' Hospital, Spoleto, Italy;(6)Division of Gastroenterology, 'Ospedali Riuniti' Hospital, Foggia, Italy;(7)Digestive Endoscopy Unit, ULSS7 Pedemontana, Santorso, Italy;(8)Digestive Endoscopy Unit, 'S. Maria Goretti' Hospital, Latina, Italy;(9)Gastroenterology and Endoscopy Unit, Department of Medicine and Surgery- University of Parma, Parma, Italy;(10)Division of Gastroenterology, 'san Giovanni-Addolorata' Hospital, Rome, Italy;(11)Division of Gastroenterology, 'Nuovo regina margherita' Territorial Hospital, Rome, Italy;(12)Department of Health Science, University of Catanzaro, Catanzaro, Italy;(13)Territorial Gastroenterology Service, Azienda Sanitaria Locale BA, Bari, Italy;(14)Division of Gastroenterology- IBD Unit, 'S. Pertini'Hospital, Rome, Italy;(15)Division of Gastroenterology- IBD Unit, 'A. Murri' Hospital, Fermo, Italy;(16)Division of Gastroenterology, 'Ciaccio-Pugliese' Hospital, Catanzaro, Italy;(17)Division of Gastroenterology, 'San Salvatore' Hospital, Pesaro, Italy;(18)Division of Gastroenterology, 'Belcolle' Hospital, Viterbo, Italy;(19)Ambulatory of Territorial Gastroenterology, Sanitary Territorial Agency, Cosenza, Italy;(20)Division of Gastroenterology- IBD Unit, 'S. Pertini' Hospital, Rome, Italy;(21)Ambulatory for IBD Treatment, 'Valle D'Itria' Hospital, Martina Franca, Italy;(22)Division of Gastroenterology, 'Annunziata Hospital', Cosenza, Italy;(23)Division of Gastroenterology, 'San Camillo Forlanini' Hospital, Rome, Italy;(24)Division of Gastroenterology, 'SS Annunziata' Hospital, Taranto, Italy;(25)Division of Gastroenterology, 'San Salvatore' Hospital, Pesaro, Italy;(26)Division of Gastroenterology, 'L. Sacco' University Hospital, Milan, Italy;(27)Division of General Surgery, 'P. Colombo' Hospital- Roma 6, Rome, Italy;(28)Division of Gastroenterology, 'S. Camillo Forlanini' Hospital, Rome, Italy;(29)Territorial Gastroenterology Service, Azienda Sanitaria Locale BAT, Andria, Italy
P584: Mucosal Eosinophilia is an Independent Predictor of Vedolizumab Effectiveness in Ulcerative ColitisECCO'21 Virtual
Year: 2021
Authors: Gremida, A.(1);Huang, K.(1);Ciorba, M.(1);Deyali , C.(1);Deepak, P.(1);
(1)Washington University in Saint Louis, Gastroenterology, Saint Louis, United States
P585: IBD Reference and Biosimilar adalimumab CroSS over Study (iBaSS): a mixed methods clinical trial of patients transitioning between originator and biosimilar adalimumab. Qualitative findings from an interim analysis presenting the patient perspective.ECCO'21 Virtual
Year: 2021
Authors: Young, D.(1);Latter, S.(2);Harvey, J.(3);Addison, J.(4);Freudensprung, U.(5);Cummings, F.(1);
(1)University Hospital Southampton NHS Foundation Trust, Department of Gastroenterology, Southampton, United Kingdom;(2)University of Southampton, School of Health Sciences, Southampton, United Kingdom;(3)Stellenbosch University, Department of Statistics and Actuarial Science, Stellenbosch, South Africa;(4)Biogen Idec, n/a, Maidenhead, United Kingdom;(5)Biogen International GmbH, n/a, Baar, Switzerland
P586: Drug-induced lipid changes in patients with Inflammatory Bowel Disease: a single center, prospective studyECCO'21 Virtual
Year: 2021
Authors: SleutjesAM, J.(1);de Vries, A.C.(1);Roeters van Lennep, J.E.(2);van der Woude, C.J.(1);
(1)Erasmus Medical Center, Gastroenterology & Hepatology, Rotterdam, The Netherlands;(2)Erasmus Medical Center, Internal Medicine, Rotterdam, The Netherlands
P587: Utility of intestinal ultrasound in Inflammatory Bowel Disease patients on management decisionsECCO'21 Virtual
Year: 2021
Authors: Abraham, B.(1);Saleh, A.(2);Perry, C.(1);
(1)Houston Methodist Hospital, Gastroenterology, Houston, United States;(2)Texas A&M University, Engineering Medicine, Houston, United States
P588: Steroid sparing effect of adalimumab in cortisone–depended ulcerative colitis patientsECCO'21 Virtual
Year: 2021
Authors: SinaDr., M.(1);Pengili, E.(1);Pemaj, X.(1);Osmanaj, D.(1);Bibolli, I.(1);Prifti, S.(1);
(1)University Hospital Center Mother Theresa, Internal Medicine/ Gastroenterology, Tirana, Albania
P589: Stable Trends in Radiation Exposure Amongst Patients with a New Diagnosis of Inflammatory Bowel Disease at an Irish Tertiary Referral HospitalECCO'21 Virtual
Year: 2021
Authors: Matthews, T.J.(1);
(1)Tallaght University Hospital, Gastroenterology, Dublin 24, Ireland
P590: Which biomarkers have an effect on therapeutic vedolizumab drug levels? A retrospective analysis from a London Tertiary Centre.ECCO'21 Virtual
Year: 2021
Authors: Bancil, A.(1);Stevens, M.(2);Kok, K.(1);
(1)The Royal London Hospital, Department of Gastroenterology, London, United Kingdom;(2)The Royal London Hospital, Department of Immunology, London, United Kingdom
P591: Anti-TNF therapy for Ulcerative Colitis in Brazil: a comparative real-world national multicentric study from the Brazilian Study Group of IBD (GEDIIB).ECCO'21 Virtual
Year: 2021
Authors: Sassaki, L.Y.(1);Magro, D.O.(2);Saad-Hossne, R.(3);Baima, J.P.(1);Flores, C.(4);Correia, L.P.D.M.P.(5);Ferrari, M.D.L.D.A.(6);Zacharias, P.(7);Feitosa, M.R.(8);Santos, C.H.M.(9);Lins Neto, M.A.D.F.(10);Quaresma, A.B.(11);Lima Junior, S.F.(12);Vasconcelos, G.B.S.(13);Cassol, O.(14);Pinto, A.D.S.(15);Kurachi, G.(16);Goncalves Filho, F.D.A.(17);Gasparini, R.G.(18);Furlan, T.K.(19);Catapani, W.(20);Coy, C.S.R.(2);Menegassi, V.D.S.(21);Colombo, M.M.(22);Froes, R.D.S.B.(23);Teixeira, F.V.(3);Moraes , A.C.(24);Santana , G.O.(25);Parente, J.M.L.(26);Vilela , E.G.(27);Kotze , P.G.(7);
(1)São Paulo State University Unesp- Medical School, Department of Internal Medicine, Botucatu, Brazil;(2)University of Campinas UNICAMP, Colorectal Surgery Unit, Campinas, Brazil;(3)São Paulo State University Unesp- Medical School, Department of Surgery, Botucatu, Brazil;(4)Hospital de Clínicas de Porto Alegre, Serviço de Gastroenterologia e Hepatologia, Porto Alegre, Brazil;(5)Hospital Universitário Onofre Lopes- Universidade Federal do Rio Grande do Norte, Gastroenterology, Natal, Brazil;(6)Medical School- Universidade Federal de Minas Gerais, Department of Clinical Medicine, Belo Horizonte, Brazil;(7)Catholic University or Paraná PUCPR, IBD outpatient Clinics- Colorectal Surgery Unit, Curitiba, Brazil;(8)Ribeirao Preto Medical School- University of Sao Paulo, Department of Surgery and Anatomy, Ribeirao Preto, Brazil;(9)Universidade Federal de Mato Grosso do Sul, Surgery Department, Campo Grande, Brazil;(10)Hospital Universitário Professor Alberto Antunes HUPAA, Service of Coloproctology, Maceió, Brazil;(11)West Santa Catarina State University UNOESC, Surgery, Joaçaba, Brazil;(12)Hospital Universitário João de Barros Barreto - UFPA, Surgery, Belém, Brazil;(13)Fundacao Universidade de Pernambuco, Gastroenterologia, Recife, Brazil;(14)Hospital de Clínicas de Passo Fundo, Surgery, Passo Fundo, Brazil;(15)Fundação Universidade do Amazonas, Gastroentorology, Manaus, Brazil;(16)Gastroclinica Cascavel, Gastroenterology, Cascavel, Brazil;(17)Faculdade Regional de Medicina de São José do Rio Preto, Surgery, São José do Rio Preto, Brazil;(18)Sete centro de especialidades médicas, Surgery, Marilia, Brazil;(19)Hospital de Clínicas da Universidade Federal do Paraná - HCUFPR, Gastroenterology, Curitiba, Brazil;(20)Faculdade de Medicina do ABC, Gastroenterology, Santo Andre, Brazil;(21)Universidade Federal de Santa Catarina, Gastroenterology, Florianópolis, Brazil;(22)Hospital Doutor Dório Silva, Gastroenterology, Serra, Brazil;(23)Gastromed, Gastroenterology, Rio de Janeiro, Brazil;(24)Hospital Copa D'Or - Rede D'Or São Luiz, Gastroenterology, Rio de Janeiro, Brazil;(25)Federal University of Bahia, IBD Unit, Salvador, Brazil;(26)Hospital Universitário da Universidade Federal do Piauí HU-UFPI, Gastroenterologia, Teresina, Brazil;(27)Clinical Hospital of the Federal University of Minas Gerais, Gastroenterology, Belo Horizonte, Brazil
P592: Costs savings associated with ferric maltol and the reduced use of intravenous iron based on real world dataECCO'21 Virtual
Year: 2021
Authors: Howaldt, S.(1,2,3);Becker, C.K.(4);Becker, J.A.(4);Poinas , A.C.(5);
(1)Hamburgisches Forschungsinstitut für chronisch entzündliche Darmerkrankungen- HaFCED e.K., Hamburgisches Forschungsinstitut für chronisch entzündliche Darmerkrankungen- HaFCED e.K., Hamburg, Germany;(2)ImmunoRegister Gug, ImmunoRegister Gug, Hamburg, Germany;(3)Medizinisches Versorgungszentrum für Immunologie, Medizinisches Versorgungszentrum für Immunologie, Hamburg, Germany;(4)Hamburgisches Forschungsinstitut für chronisch entzündliche Darmerkrankungen- HaFCED e.K., Medical department, Hamburg, Germany;(5)Norgine Ltd, Global Market Access & Public Affairs, Harefield, United Kingdom
P593: Ustekinumab for the treatment of perianal Crohn’s disease. A real-world experience in a Spanish hospitalECCO'21 Virtual
Year: 2021
Authors: Algara San Nicolas, M.(1);Masedo Gonzalez, A.(1);Gomez Gomez, G.J.(1);Yela San Bernardino, C.(1);Casis Herce, B.(1);Martinez Montiel, M.P.(1);
(1)Hospital 12 de Octubre, Gastroenterology, Madrid, Spain
P594: Utilisation of anti-TNF agents in phlegmonous Crohn’s disease: an Australian tertiary referral centre experienceECCO'21 Virtual
Year: 2021
Authors: Chiu, L.(1);Digby-Bell, J.(2);Seah, J.(1,3);Melton, S.(1,4);Taylor, K.(1,2);Sparrow, M.(1,2);
(1)Monash University, Faculty of Medicine- Nursing and Health Sciences, Melbourne, Australia;(2)Alfred Health, Department of Gastroenterology, Melbourne, Australia;(3)Alfred Health, Department of Radiology, Melbourne, Australia;(4)Alfred Health, Nutrition Department, Melbourne, Australia
P595: Finding predictors of azathioprine-induced pancreatitis in patients with inflammatory bowel diseaseECCO'21 Virtual
Year: 2021
Authors: Freitas, M.(1,2,3);Capela, T.(1,2,3);Macedo Silva, V.(1,2,3);Arieira, C.(1,2,3);Cúrdia Gonçalves, T.(1,2,3);Dias de Castro, F.(1,2,3);Moreira, M.J.(1,2,3);Cotter, J.(1,2,3);
(1)Hospital da Senhora da Oliveira, Gastroenterology Department, Guimarães, Portugal;(2)Life and Health Sciences Research Institute ICVS, School of Medicine- University of Minho, Braga, Portugal;(3)ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal
P596: Trough concentration of ustekinumab was a useful biomarker for the prediction of treatment-effects in patients with Crohn’s Diseases.ECCO'21 Virtual
Year: 2021
Authors: Kato, S.(1);Yamaga, N.(1);Ishibashi, A.(1);Kani, K.(1);Yakabi, K.(1);Nagoshi, S.(1);
(1)Saitama Medical Centre- Saitama Medical University, Department of Gastroenterology and Hepatology, Kawagoe City- Saitama, Japan